ArticleFrontiers in oncology2026

Impact of quality control indicator system management program on neoadjuvant and adjuvant therapies for breast cancer: a comparative analysis.

Silu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.